Morgan Stanley, India Life Sciences funds acquire control of Maiva Pharma, invest Rs 1,000 crore
The company plans to use the proceeds of the investment to set up a new manufacturing facility near Hosur.
Source: moneycontrol.com
Nirav Mehta News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nirav Mehta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nirav Mehta Today - Breaking & Trending Today
Maiva Pharma: Maiva Pharma raises Rs 1000 crore from Morgan Stanley Private Equity, InvAscent
Morgan Stanley PE Asia and India Life Sciences Fund are investing almost equally, total stake with both funds combined will be over 60% post primary investment, the company told ET.
Source: indiatimes.com
Injectables maker Maiva Pharma raises ₹1,000 crore to set up new manufacturing unit
The company has a portfolio of over 75 products in CDMO services across the US, Canada, Europe, Australia, and LATAM markets.
Source: livemint.com
Morgan Stanley: Maiva Pharma raises Rs 1,000 cr from Morgan Stanley PE and India Life Sciences Fund
Maiva Pharma has raised Rs 1,000 crore from Morgan Stanley Private Equity Asia and India Life Sciences Fund, including both primary and secondary funding. The funds will be used to set up a new manufacturing facility near Karnataka's Hosur, with capabilities in sterile dosage forms, including pre-filled syringes, bags, oncology, and hormonal injectables. Maiva's complex injectables development and manufacturing capability, strong compliance and regulatory standards, and transparency differentiate the company from competitors.
Source: indiatimes.com
Morgan Stanley: Maiva Pharma raises Rs 1,000 crore from Morgan Stanley PE and India Life Sciences Fund
India Business News: Maiva Pharma on Thursday said it has raised Rs 1,000 crore from Morgan Stanley Private Equity Asia and India Life Sciences Fund.
Source: indiatimes.com